These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Incidence and severity of treatment-induced hypoglycemias in diabetics]. Hasslacher C; Wahl P Dtsch Med Wochenschr; 1971 Nov; 96(46):1787-91. PubMed ID: 5000535 [No Abstract] [Full Text] [Related]
3. Hypoglycemia presenting as hemiparesis in a diabetic patient. Bhatia RS J Assoc Physicians India; 1992 Feb; 40(2):136-7. PubMed ID: 1629131 [No Abstract] [Full Text] [Related]
4. [88 severe incidents of hypoglycemia in patients under treatment with sulfonylurea compounds. Results of a survey throughout Switzerland during 1968 and 1969]. Berger W Schweiz Med Wochenschr; 1971 Jul; 101(28):1013-22. PubMed ID: 5141777 [No Abstract] [Full Text] [Related]
5. [The risk of hypoglycemia in sulfonylurea therapy]. Berger W; Koller F Helv Med Acta; 1972 Apr; 36(2):228-9. PubMed ID: 5029101 [No Abstract] [Full Text] [Related]
6. The role of hypoglycemic sulphonylureas in arrhythmias contributing to the mortality in acute myocardial ischemia. Koltai MZ; Aranyi Z; Ballagi-Podány G; Pogátsa G Acta Physiol Hung; 1990; 75 Suppl():175-6. PubMed ID: 2371854 [No Abstract] [Full Text] [Related]
7. Hypoglycaemic hemiparesis in a Nigerian alcoholic. Imam I Afr J Med Med Sci; 2004 Dec; 33(4):377-80. PubMed ID: 15977448 [TBL] [Abstract][Full Text] [Related]
8. Sulphonylureas--action and uses. Ferrier TM Aust Fam Physician; 1976 Jul; 5(6):865-6. PubMed ID: 999566 [TBL] [Abstract][Full Text] [Related]
9. [Hypoglycemia]. Fagulha A Acta Med Port; 1989 Sep; Suppl 1():25S-26S. PubMed ID: 2694771 [TBL] [Abstract][Full Text] [Related]
10. Recurrent sulfonylurea induced nocturnal hypoglycemia managed with tolbutamide. Borst GC J Ky Med Assoc; 1988 Mar; 86(3):129-30. PubMed ID: 3356924 [No Abstract] [Full Text] [Related]
11. [Unusual clinical forms of hypoglycemic reactions in the treatment of diabetes mellitus]. Anghelescu L; Băcanu G Med Interna (Bucur); 1970 Apr; 22(4):481-8. PubMed ID: 5419093 [No Abstract] [Full Text] [Related]
12. [Modern treatment of diabetes mellitus with sulfonylurea compounds]. Haller H; Hanefeld M; Leonhardt W Z Arztl Fortbild (Jena); 1979 May; 73(10):482-7. PubMed ID: 158261 [No Abstract] [Full Text] [Related]
14. [Hypoglycemic hemiparesis. A case report]. Fagan M Tidsskr Nor Laegeforen; 1989 Sep; 109(27):2773-4. PubMed ID: 2815007 [TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2. Jackson JE; Bressler R Drugs; 1981 Oct; 22(4):295-320. PubMed ID: 7030708 [No Abstract] [Full Text] [Related]
16. [Adverse effects and interactions of oral antidiabetics]. Czyzyk A; Stryjek-Kamińska D Pol Tyg Lek; 1980 Nov; 35(45):1757-60. PubMed ID: 7012809 [No Abstract] [Full Text] [Related]
17. [Hypoglycemic states during sulfonylurea therapy]. Gurtner B; Bäbler M; Wegmann T Ther Umsch; 1969 May; 26(5):283-7. PubMed ID: 5801613 [No Abstract] [Full Text] [Related]
18. Transient hypoglycemic hemiparesis in children with IDDM. Spallino L; Stirling HF; O'Regan M; Ross L; Zampolli M; Kelnar CJ Diabetes Care; 1998 Sep; 21(9):1567-8. PubMed ID: 9727911 [No Abstract] [Full Text] [Related]
19. Predictors of relapse in elderly diabetic patients admitted with sulphonylurea-induced severe hypoglycaemic attacks. Chan TY; Cheung AY Age Ageing; 1997 Sep; 26(5):409-10. PubMed ID: 9351488 [No Abstract] [Full Text] [Related]
20. [Clinical testing of Ro 6-4563--a new peroral anti-diabetic preparation]. Berchtold P; Fagerberg SE Lakartidningen; 1971 Sep; 68(40):4503-7. PubMed ID: 4944538 [No Abstract] [Full Text] [Related] [Next] [New Search]